Efficacy of a digital therapeutics system in the management of essential hypertension: the HERB-DH1 pivotal trial
| Autor: | Eisuke Hida, Kiyose Nakagawa, Ayako Okura, Akihiro Nomura, Kazuomi Kario, Noriko Harada, Tomoyuki Tanigawa |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Lifestyle modification
medicine.medical_specialty Ambulatory blood pressure Hypertension Pulmonary Population Fast Track Clinical Research Blood Pressure Essential hypertension law.invention Randomized controlled trial law Internal medicine Humans Medicine AcademicSubjects/MED00200 Prospective Studies education Life Style Antihypertensive Agents education.field_of_study business.industry Surrogate endpoint Home blood pressure Epidemiology and Prevention Blood Pressure Monitoring Ambulatory medicine.disease Confidence interval Treatment Outcome Blood pressure Hypertension Ambulatory Essential Hypertension Digital therapeutics Cardiology and Cardiovascular Medicine business |
| Zdroj: | European Heart Journal |
| ISSN: | 1522-9645 0195-668X |
| Popis: | Aims Digital therapeutics is a new approach to facilitate the non-pharmacological treatment of hypertension using software programmes such as smartphone applications and/or device algorithms. Based on promising findings from a small pilot trial, the HERB Digital Hypertension 1 (HERB-DH1) pivotal trial investigated the efficacy of digital therapeutics in patients with hypertension not receiving antihypertensive medication. Methods and results This prospective, open-label, randomized controlled study was performed at 12 sites in Japan. Patients with hypertension [office systolic blood pressure (SBP) 140 to Graphical Abstract |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|